Topic

Aetna (CVS Health)

A collection of 640 issues

How to Get Amondys 45 (Casimersen) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Amondys 45 Covered by Aetna CVS Health in North Carolina Aetna CVS Health requires prior authorization for Amondys 45 (casimersen) with strict documentation: genetic testing confirming exon 45-amenable DMD mutation, age under 14, specialist prescription, and detailed monitoring plan. If denied, North Carolina residents can appeal internally
6 min read

How Long Does It Take to Get Sylvant (Siltuximab) Approved by Aetna (CVS Health) in Virginia? Complete Timeline & Appeals Guide

Answer Box: Getting Sylvant (Siltuximab) Covered by Aetna (CVS Health) in Virginia Timeline: Aetna (CVS Health) typically decides prior authorization requests for Sylvant (siltuximab) within 14-30 days for standard cases, or 72 hours for urgent requests. After approval, CVS Specialty coordinates the first fill within 2-5 business days. Fastest path:
6 min read

How to Get Pomalyst (pomalidomide) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Pomalyst Covered by Aetna CVS Health in Pennsylvania Pomalyst (pomalidomide) requires prior authorization from Aetna CVS Health in Pennsylvania. Your fastest path to approval: (1) Ensure REMS program enrollment is complete, (2) Submit PA request with documented lenalidomide and proteasome inhibitor failure, and (3) Include oncologist attestation.
5 min read

Do You Qualify for Imbruvica (ibrutinib) Coverage by Aetna (CVS Health) in Ohio? Decision Tree & Next Steps

Answer Box: Quick Eligibility Check You likely qualify for Imbruvica (ibrutinib) coverage by Aetna (CVS Health) in Ohio if you have: * FDA-approved diagnosis (CLL/SLL, Waldenström macroglobulinemia, or chronic GVHD) * Complete pathology confirming your specific condition * Documentation of prior treatment failures (if required by step therapy) Fastest path to approval:
5 min read